Episurf Medical AB (EPISB.ST)

Nasdaq Stockholm · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Episurf Medical AB reported revenue of SEK 13.0M and net income of −SEK 76.0M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	SEK 13.0M	SEK 10.3M	SEK 6.6M	SEK 6.5M	SEK 5.0M
Operating income	−SEK 77.2M	−SEK 96.7M	−SEK 77.0M	−SEK 69.4M	−SEK 63.4M
Net income	−SEK 76.0M	−SEK 94.8M	−SEK 77.3M	−SEK 69.3M	−SEK 63.9M
Diluted EPS	−SEK 0.15	−SEK 0.30	−SEK 0.29	−SEK 0.31	−SEK 0.39
Cash flow
Operating cash flow	−SEK 71.4M	−SEK 84.8M	−SEK 69.5M	−SEK 59.7M	−SEK 54.1M
Capital expenditure	SEK 0	SEK 0	SEK 0	SEK 100.0K	SEK 0
Free cash flow	−SEK 71.4M	−SEK 84.8M	−SEK 69.5M	−SEK 59.8M	−SEK 54.1M
Balance sheet
Cash and equivalents	SEK 50.5M	SEK 57.9M	SEK 155.3M	SEK 237.9M	SEK 155.0M
Total assets	SEK 97.8M	SEK 104.3M	SEK 197.2M	SEK 270.6M	SEK 185.4M
Total liabilities	SEK 13.9M	SEK 19.8M	SEK 19.5M	SEK 17.8M	SEK 16.0M
Shareholders' equity	SEK 83.8M	SEK 84.5M	SEK 177.7M	SEK 252.8M	SEK 169.5M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full EPISB.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open EPISB.ST financials →